Population Health Science and Policy

Search results

• Mesoblast (MSB: $A1.15) hits eight-month high

  Eric Rose

  5/12/22

  1 item of Media coverage

  Press/Media

• Weekly: Mesoblast (MSB: $A1.10) in top 6% performers of All Ordinaries Index in past week; +9.5c [9.4%]

  Eric Rose

  5/12/22

  1 item of Media coverage

  Press/Media

• Research from Institute for Health Provides New Data on Legal Issues (A changing supply chain for a changing health care system: Barriers and facilitators of implementing enterprise resource planning)

  Ksenia Gorbenko & Madhu Mazumdar

  2/12/22

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Report New Studies and Findings in the Area of Clinical Oncology (Cost-effectiveness Frameworks for Comparing Genome and Exome Sequencing Versus Conventional Diagnostic Pathways: a ...)

  Bart Ferket & Bruce Gelb

  1/12/22

  1 item of Media coverage

  Press/Media

• Monthly: Mesoblast (MSB: $A1.10) shares post best month in four months

  Eric Rose

  30/11/22

  1 item of Media coverage

  Press/Media

• Let’s Talk About Light and Health Series – Equal Lights: Projects Focused on Health Equity

  Carol Horowitz

  30/11/22

  1 item of Media coverage

  Press/Media

• MESOBLAST - AUSTRALIAN PRE-MARKET CONFIRMATORY BULLISH MOMENTUM SIGNAL Thursday December 01, 2022 08:12 AEDT

  Eric Rose

  30/11/22

  1 item of Media coverage

  Press/Media

• PHOTO GALLERY: AHA 2022

  Leslee Shaw

  29/11/22

  1 item of Media coverage

  Press/Media

• Investigators from Mount Sinai Hospital Have Reported New Data on COVID-19 (Comparison of Total Joint Arthroplasty Care Patterns Prior To the Covid-19 Pandemic and After Resumption of Elective Surgery During the Covid-19 Outbreak: a ...)

  Nicole Zubizarreta & Jashvant Poeran

  29/11/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 99.0c) falls 2.0%

  Eric Rose

  28/11/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 99.0c) - PRE-MARKET CONFIRMATORY BEARISH SIGNAL FROM ITS ADR MARKET Tuesday November 29, 2022 08:11 AEDT

  Eric Rose

  28/11/22

  1 item of Media coverage

  Press/Media

• Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury

  Gregg Stone

  28/11/22

  103 items of Media coverage

  Press/Media

• Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury

  Gregg Stone

  28/11/22

  1 item of Media coverage

  Press/Media

• Oxitope Appoints Leading Interventional Cardiologist Gregg Stone to Advisory Board for Myocardial Reperfusion Injury

  Gregg Stone

  28/11/22

  1 item of Media coverage

  Press/Media

• Weekly: Mesoblast (MSB: $A1.01) in top 5% performers of All Ordinaries Index in past week; +8c [8.6%]

  Eric Rose

  28/11/22

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Describe Findings in COVID-19 (Characterizing Delayed Care Among Us Older Adults By Self-rated Health During the Covid-19 Pandemic)

  Bian Liu, Yan Li, Weixin Li & Julia Frydman

  25/11/22

  1 item of Media coverage

  Press/Media

• Findings from University of Miami Reveals New Findings on Pancreatic Cancer (Racial Disparity In Pathologic Response Following Neoadjuvant Chemotherapy In Resected Pancreatic Cancer: a Multi-institutional Analysis From the Central Pancreatic ...)

  Deukwoo Kwon

  24/11/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: $A1.01) closes at 6.3% above VWAP

  Eric Rose

  24/11/22

  1 item of Media coverage

  Press/Media

• Investigators from Zhejiang University Have Reported New Data on Fahr Disease (Ischemic Stroke In a Patient With Fahr's Disease Carrying Biallelic Mutations In the Myorg Gene)

  Yan Li

  24/11/22

  1 item of Media coverage

  Press/Media

• Shanghai Jiao Tong University School of Medicine Researcher Provides New Data on Brain Injury (Dualistic roles and mechanistic insights of macrophage migration inhibitory factor in brain injury and neurodegenerative diseases)

  Yan Li

  24/11/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: $A1.01) - PRE-MARKET CONFIRMATORY BULLISH SIGNAL FROM ITS ADR MARKET Friday November 25, 2022 08:11 AEDT

  Eric Rose

  24/11/22

  1 item of Media coverage

  Press/Media

• New Data from University of Miami Miller School of Medicine Illuminate Research in B-Cell Lymphoma (A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma)

  Deukwoo Kwon

  24/11/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 98.50c) falls 1.0%

  Eric Rose

  23/11/22

  1 item of Media coverage

  Press/Media

• Mesoblast Limited (MESO) Q1 2023 Earnings Call Transcript

  Eric Rose

  23/11/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 98.50c) - PRE-MARKET CONFIRMATORY BEARISH SIGNAL FROM ITS ADR MARKET Thursday November 24, 2022 08:11 AEDT

  Eric Rose

  23/11/22

  1 item of Media coverage

  Press/Media